Early-life exposure to Ivermectin alters long-term growth and disease susceptibility.
Ivermectin is a broad-spectrum antiparasitic medicine, which is often used as a treatment for parasites or as a prophylaxis. While studies have looked at the long-term effects of Ivermectin on helminths, studies have not considered the long-term impacts of this treatment on host health or disease su...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0e9238b31c4346c1a233631d96d67c42 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:0e9238b31c4346c1a233631d96d67c42 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:0e9238b31c4346c1a233631d96d67c422021-12-02T20:13:42ZEarly-life exposure to Ivermectin alters long-term growth and disease susceptibility.1932-620310.1371/journal.pone.0258185https://doaj.org/article/0e9238b31c4346c1a233631d96d67c422021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0258185https://doaj.org/toc/1932-6203Ivermectin is a broad-spectrum antiparasitic medicine, which is often used as a treatment for parasites or as a prophylaxis. While studies have looked at the long-term effects of Ivermectin on helminths, studies have not considered the long-term impacts of this treatment on host health or disease susceptibility. Here, we tracked the effects of early life Ivermectin treatment in Cuban tree frogs (Osteopilus septentrionalis) on growth rates, mortality, metabolically expensive organ size, and susceptibility to Batrachochytrium dendrobatidis (Bd) infection. One year after exposure, there was no effect of Ivermectin exposure on frog mass (X21 = 0.904, p = 0.34), but when tracked through the exponential growth phase (~2.5 years) the Ivermectin exposed individuals had lower growth rates and were ultimately smaller (X21 = 7.78, p = 0.005; X21 = 5.36, p = 0.02, respectively). These results indicate that early life exposure is likely to have unintended impacts on organismal growth and potentially reproductive fitness. Additionally, we exposed frogs to Bd, a pathogenic fungus that has decimated amphibian populations globally, and found early life exposure to Ivermectin decreased disease susceptibility (disease load: X21 = 17.57, p = 0.0002) and prevalence (control: 55%; Ivermectin: 22%) over 2 years after exposure. More research is needed to understand the underlying mechanism behind this phenomenon. Given that Ivermectin exposure altered disease susceptibility, proper controls should be implemented when utilizing this drug as an antiparasitic treatment in research studies.Taegan A McMahonShannon Fernandez-DenmarkJeffrey M GrimPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 10, p e0258185 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Taegan A McMahon Shannon Fernandez-Denmark Jeffrey M Grim Early-life exposure to Ivermectin alters long-term growth and disease susceptibility. |
description |
Ivermectin is a broad-spectrum antiparasitic medicine, which is often used as a treatment for parasites or as a prophylaxis. While studies have looked at the long-term effects of Ivermectin on helminths, studies have not considered the long-term impacts of this treatment on host health or disease susceptibility. Here, we tracked the effects of early life Ivermectin treatment in Cuban tree frogs (Osteopilus septentrionalis) on growth rates, mortality, metabolically expensive organ size, and susceptibility to Batrachochytrium dendrobatidis (Bd) infection. One year after exposure, there was no effect of Ivermectin exposure on frog mass (X21 = 0.904, p = 0.34), but when tracked through the exponential growth phase (~2.5 years) the Ivermectin exposed individuals had lower growth rates and were ultimately smaller (X21 = 7.78, p = 0.005; X21 = 5.36, p = 0.02, respectively). These results indicate that early life exposure is likely to have unintended impacts on organismal growth and potentially reproductive fitness. Additionally, we exposed frogs to Bd, a pathogenic fungus that has decimated amphibian populations globally, and found early life exposure to Ivermectin decreased disease susceptibility (disease load: X21 = 17.57, p = 0.0002) and prevalence (control: 55%; Ivermectin: 22%) over 2 years after exposure. More research is needed to understand the underlying mechanism behind this phenomenon. Given that Ivermectin exposure altered disease susceptibility, proper controls should be implemented when utilizing this drug as an antiparasitic treatment in research studies. |
format |
article |
author |
Taegan A McMahon Shannon Fernandez-Denmark Jeffrey M Grim |
author_facet |
Taegan A McMahon Shannon Fernandez-Denmark Jeffrey M Grim |
author_sort |
Taegan A McMahon |
title |
Early-life exposure to Ivermectin alters long-term growth and disease susceptibility. |
title_short |
Early-life exposure to Ivermectin alters long-term growth and disease susceptibility. |
title_full |
Early-life exposure to Ivermectin alters long-term growth and disease susceptibility. |
title_fullStr |
Early-life exposure to Ivermectin alters long-term growth and disease susceptibility. |
title_full_unstemmed |
Early-life exposure to Ivermectin alters long-term growth and disease susceptibility. |
title_sort |
early-life exposure to ivermectin alters long-term growth and disease susceptibility. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2021 |
url |
https://doaj.org/article/0e9238b31c4346c1a233631d96d67c42 |
work_keys_str_mv |
AT taeganamcmahon earlylifeexposuretoivermectinalterslongtermgrowthanddiseasesusceptibility AT shannonfernandezdenmark earlylifeexposuretoivermectinalterslongtermgrowthanddiseasesusceptibility AT jeffreymgrim earlylifeexposuretoivermectinalterslongtermgrowthanddiseasesusceptibility |
_version_ |
1718374748184903680 |